Lataa...
Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management
It is well known that hepatitis B virus reactivation (HBVr) can occur among patients undergoing treatment for hematological malignancies (HM). The evaluation of HBVr risk in patients undergoing immunosuppressive treatments is a multidimensional process, which includes conducting an accurate clinical...
Tallennettuna:
| Julkaisussa: | Viruses |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6784078/ https://ncbi.nlm.nih.gov/pubmed/31540124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11090858 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|